Physician profile
Christopher S Choi
NPI 1730117656
$6,679.40
in general payments reported to CMS, 2019-2025
45 companies · $554 in 2025
The $554 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $341 · 2021: $1,971 · 2022: $1,197 · 2023: $1,095 · 2024: $1,103 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,719 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,719.43 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,372.94 | 2020-2025 | Repatha, Repatha, Otezla |
| Biohaven Pharmaceuticals, INC. | $1,243.81 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $647.43 | 2019-2025 | Farxiga, Airsupra |
| Abbvie INC. | $337.69 | 2022-2025 | Vraylar, Qulipta |
| Novo Nordisk INC | $302.84 | 2019-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $252.26 | 2023-2025 | |
| Eisai INC. | $203.37 | 2020-2022 | |
| Abbott Laboratories | $183.94 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Teleflex LLC | $179.39 | 2024 | Urolift |
| Lilly USA, LLC | $167.33 | 2023-2024 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $165.49 | 2019-2025 | Jardiance |
| Radius Health, INC. | $149.12 | 2023-2025 | Tymlos |
| Corcept Therapeutics | $135.67 | 2022-2023 | Korlym |
| Avanir Pharmaceuticals, INC. | $129.73 | 2019-2021 | |
| Ucb, INC. | $123.50 | 2019-2021 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.